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Abstract

The research presented here explored the role of endogenous opioid mechanisms in
alcohol reinforcement. Alcohol was introduced to naïve mice under food deprivation or ad
libitum food availability three times. Deprived and non-deprived mice were administered
naloxone or vehicle after each exposure to ethanol or water. The animals were subsequently
given a two bottle test of alcohol preference. The animals exposed to alcohol under deprivation
and given vehicle showed a preference for alcohol over all other groups. Animals given naloxone
after exposure to alcohol while deprived showed lower alcohol preference and did not differ
from controls. These data show that the enhanced reinforcing and incentive effects of alcohol
when initially presented under high food need is blocked by the opioid antagonist naloxone and
suggests that these motivating effects of alcohol are mediated in part by endogenous opioid
systems. Naloxone in suppression of alcohol preference and intake may be an effective tool in
the treatment of alcohol addiction.
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1.1 Statement of purpose
Recent figures from the National Institute of Drug Addiction indicate that alcoholism
affects upwards of 17.3 million Americans, more than 6% of the total population. (“Nationwide
trends”, 2015), and that deleterious health outcomes for individuals struggling with alcoholism
are a strain on our national healthcare system (“Excessive drinking is draining the U.S.
economy”, 2016). In order to create clinical programs that can cope more effectively with this
issue, it’s essential to investigate not only the physiological changes that accompany addiction,
but also the motivational changes that arise both as a consequence of and a determinant of
addiction reinforcement. While current research has explored many of the external conditions
that motivate reinforcement in alcohol addiction (i.e. incentive mechanisms), our understanding
of the internal mechanisms that mediate these motivational factors and how intervention might
disrupt these mechanisms remains an important research issue.
1.2 Defining addiction
To understand how addiction develops and is reinforced is to stand at the crossroad of
motivation where issues of need, want, liking and other behavioral states intersect with
physiology, neurochemistry, and genetics. It is a complex state that is difficult to unravel. This is
further complicated by the fact that alcohol is the only drug of abuse that provides nutritional
value - delivering around 80 calories per ounce - and that nutritional content may constitute up to
50% of the caloric intake of an alcohol dependent individual (Lewis, 1996). The mechanisms
that mediate reinforcement of alcohol addiction are many and varied, and their study requires
multiple behavioral and neurobiological approaches.
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Neurochemical Mechanisms
Many neurochemical systems are involved in the development and maintenance of
addiction such as glutamate (D’Souza, 2015), GABA (Tan et al., 2011), and cannabinoids
(Maldonado et al., 2006); however, dopamine (DA) has been implicated most widely in
neurochemical accounts of addiction (Wise, 1980) and its continued study has produced the most
consistent and reproduced models of addiction reinforcement. Originating in the ventral
tegmental area (VTA) of the brain, DA neurons then ascend through the nucleus accumbens
(NAc) and ventral striatum to the prefrontal cortex (PFC) (Berridge & Kringlebach, 2015). In
this way, the mesocorticolimbic DA system connects that which is most reptilian in the brain
with that which is most singularly human. DA receptors (DAR) types are differentiated by their
mode of action: members of the D1 receptor family are G-coupled receptor proteins which
increase the concentration of cAMP in the cell, whereas members of the D2 receptor family are
G-coupled receptor proteins which inhibit the formation of cAMP in the cell (Carlson & Birkett,
2016). Both types have been implicated in reward, motivation and addiction (many references).
A growing body of literature suggests that D2 receptor availability specifically plays a
significant role in addiction. This includes genetic data: Bice et al. (2008) selectively bred high
alcohol-preferring mice and then mapped their genome. Compared to control mice, high alcoholpreferring mice expressed lower levels of the gene responsible for the production of the D2
receptor. Additionally mice given chronic intermittent alcohol exhibit a massive loss of D2
modulation (Trantham-Davidson et al., 2014). Finally, this hypothesis is bolstered by clinical
data showing that Type II alcoholics show lower striatal D2 receptor availability than healthy
controls (Volkow et al., 2002).
While initially conceived of as the neurochemical most associated with pleasure in the
brain, a waystation for the translation of stimulus into hedonic salience, many today believe that
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DA may play a more limited motivational role (Berridge & Kringlebach, 2015). Some now
believe that the mesocorticolimbic DA system may be a key part of our motivational system that
encodes memories of reward experiences with events that preceded them (Volkow et al., 2017).
With drugs of abuse like alcohol, the initial exposure produces an increase in striatal DA (Lewis,
1996), phasic activation results in widespread downregulation of D2 receptors (Volkow et al.,
2017).
D2 receptor availability not only mediates addiction but eating disorders as well. This is
not surprising, given the fact that addiction and food intake share a common pathway by way of
the mesocorticolimbic system via the hypothalamus (Volkow et al., 2011). VTA DA neurons
express receptors instrumental in the homeostatic control of food intake such as leptin, amylin,
and ghrelin (Volkow et al., 2017). Clinically, subjects with morbid obesity were found to have
decreased striatal D2 levels (Volkow et al., 2008), and, furthermore, that chronic high-fat diet
consumption decreased the brain reward threshold as a consequence of D2 receptor
downregulation, leading to the individual consuming more of the diet in order to attain the same
level of reward (Reyes, 2012).
If changes in the DA system reflect changes in motivation, changes in hedonic tone may
involve other mechanisms. Endogenous opioid systems have been hypothesized to play a role in
the positive hedonic qualities of motivational stimuli. Endogenous opioid receptors are of four
types - three “classical” receptors (mu-opioid (MOP) receptor, delta-opioid (DOP) receptor, and
kappa-opioid (KOP) receptor) and one “non-classical” receptor (nociceptin orphanin FQ peptide
receptor) - and are present in high concentration, among other locations, along the mesolimbic
and mesocortical pathways associated with reward and motivation (Nutt, 2014). Proopiomelanocortin (POMC), a key opioid precursor, is of particular import to the study of
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addiction: it gives rise to β-endorphin. A neural system which projects from the arcuate nucleus
onto regions associated with the mesolimbic DA system such as the VTA and NAc, β-endorphin
binds to both MOP and DOP (Gianoulakis, 2001).
Research with other drugs of abuse (e.g. cocaine) has shown that activation of the D2
system recruits activation of an endogenous opioid peptide that binds to MOP (Soderman &
Unterwald, 2009). Likewise, ethanol diets have been shown to “cause an increase in the
maximum number of both μ- and δ-receptors in experimental animals” (Herz, 1997). Also the
release of endogenous opioid in response to ethanol administration is similar to that of DA.
Ethanol administration increases β-endorphin in the short-term which interacts with specific
MOP and DOP receptors to mediate the neurobehavioral effect of the drug. Prolonged exposure
to ethanol, however, results in a decreased β-endorphin release as an adaptive measure to
counterbalance the effect of alcohol retain functioning at baseline levels which produces a
hedonic change in the absence of ethanol (Gianoulakis, 2001). This change in hedonic quality
may reflect neurochemical changes that occur with the development of physical dependence
(withdrawal) with chronic administration of opioids. The presence of the withdrawal symptoms
intensifies motivation leading to increased opioid intake and other aspects of additive behavior.

Motivational Mechanisms
The mechanisms in the development of addiction involve those that mediate changes with
chronic administration (withdrawal) and motivation. One principle change is the activation of
brain aversion systems that mediate negative hedonic effects produced by the absence of the drug
of abuse. Whereas initial exposure activates positive reinforcement through increased DA and
endogenous opioid receptor activation, prolonged exposure may lead to a homeostatic response
to repetitive activation of reward systems producing aversion mediated by corticotropin-releasing
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factor (CRF) and dynorphin in the amygdala. These responses are components of stress and may
lead to other consequences in addition to aversion (Koob, 2017).
Over time, consumption of drugs of abuse that may have started as goal-directed behavior
becomes habitual, leading to a significant change in motivation and a resistance to devaluation of
the stimulus. This is mirrored by the change in positive reinforcement (seeking positive hedonic
effects) to negative reinforcement (avoidance of negative hedonic effects) (Koob & Volkow,
2010). These motivational behavioral changes are enhanced by observed changes in neural
connectivity: electrophysiological data of animals performing a food reinforced task showed
dorsal medial striatum (DMS) activation during the acquisition phase of the experiment that
transitioned to dorsal lateral striatum (DLS) activity during habitual performance (Everitt &
Robbins, 2015). Changes in DLS DA signaling have been associated with cue-induced cocaine
craving (Everitt & Robbins, 2015), and may represent a site of relevance to the negative affect
that leads to feelings of need in avoidance of withdrawal.
Changes in incentive relevance accompany and make possible changes in need to
consume drugs of abuse: the importance of environmental cues associated with drugs of abuse
reflects a neurochemical imbalance that directed consumption seeks to rectify. The
neurochemical imbalance focuses and enhances the effects of environmental cues that are
associated with consumption of the drug of abuse. In this respect, we can understand compulsive
drug use as a need of a kind similar to the need for food. As has been explored previously, drug
reward and motivation pathways share neural connectivity with pathways mediating food
consumption. In the same way that nutritional deficit motivates food consumption behavior,
mesolimbic D2 dysregulation can be conceptualized as creating a need that motivates drug
consumption behavior (Atzram, 2015).
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The way these systems interact with one another and create compounding effects can be
seen in research on addiction reinforcement and deprivation. Studies using food deprivation and
ethanol intake have been explored since 1901, but early explanations for increased ethanol
consumption following deprivation attributed this outcome to alcohol’s caloric content; it wasn’t
until the paradigm was used as part of an operant conditioning protocol that this was shown not
to be the case, since ethanol drinking decreased but still remained higher than water consumption
in control group rats when the intermittent schedule of food administration was removed and the
animals were allowed to eat until sated (Carroll and Meisch, 1984). Indeed, the effect has been
replicated with other drugs of abuse that do not have caloric content like stimulants and
depressants, and there, too, a period of deprivation preceding drug administration increased
intake (Meisch, 1984). The neurochemical explanation for this effect could be attributable to
enhanced functional activity of DA receptors during food deprivation, either enhancing release,
minimizing reuptake, or augmenting the D1 receptor pathway (Carr, 2002), which in turn enables
an increased effect of D1/D2 synergism in the NAc (Hasbi et al., 2011).
1.3 The C57Bl/6 Mouse
The C57BL/6 mouse (C57) is the standard model for mouse research - not only is the
strain possessing of a remarkable stability, widespread use, and is easily bred (Battey et al.,
1999), but for those very reasons it was selected as the first organism to have its genome
recorded outside of humans. This popularity may have been motivated in part by to the strain’s
outsized preference for ethanol consumption. In a survey of voluntary ethanol consumption in
15 commonly used inbred mouse strains, the C57 reigned supreme in the amount of ethanol
consumed at low and high concentrations (3% and 10% respectively) in addition to exhibiting
the lowest incidence of avoidance (Belknap et al., 1993).
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Part of this effect can be explained by genotypic variation. Compared to DBA/2 mice, a
strain with just as strong of an outsized avoidance for alcohol, the C57 mouse has a lower density
of D2 receptor mRNA abundance in the hypothalamus (Ng et al., 1994), a finding consistent
with assumptions of the DA hypothesis of addiction explored above.
1.4 Naloxone antagonism of ethanol and reinforcement effects
First patented in 1961 to treat constipation induced by chronic opioid use (“The history of
naloxone”, 2017), naloxone is now widely used as an over the counter tool to reverse acute
opioid overdose (“Is naloxone accessible?”, 2018). Naloxone acts as an opioid antagonist,
reversing the effect of opioids by competing for the same binding sites with higher affinities and
thereby resolving attendant central nervous system depression, sedation, and hypotension in an
individual experiencing overdose (“Narcan prescribing information”, 2017). Naloxone is not a
selective antagonist - though it has a predominantly high nanomolar affinity for MOP, it also
demonstrates a nanomolar affinity for KOP (Nutt, 2014).
Naloxone administration has been shown to modulate the reinforcing and motivational
components of drugs of abuse (e.g. cocaine) in subjects as shown by Kuzmin et al. (1997). In
their first experiment, mice were pre-treated with either naloxone, naloxone-methyl iodide
(NMI) (a form of naloxone that does not cross the blood brain barrier), or saline solution before a
period of self-administration of cocaine at graded doses. The administration of naloxone shifted
the dose-response curve to the right, and significantly blunted the reinforcement effect (i.e. less
self-administration) of 0.4µg cocaine at 1 mg/kg compared to both equal concentrations of
placebo or NMI. Furthermore, 1mg/kg of naloxone had a significant effect on conditioned place
preference for animals conditioned with 10 mg/kg cocaine, significantly decreasing the amount
of time spent in the drug paired side of a two compartment box compared to equal concentrations
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of placebo or NMI. Because neither of these effects were exhibited with the administration of
NMI, the opioid blockade’s influence on reinforcement occurs centrally, not peripherally.
Due to the close interrelation of the DA mesolimbic systems and endogenous opioid
receptor systems explored above, naloxone has been explored as a potential avenue to interrupt
patterns of alcohol dependence. Indeed, administration of opioid receptor agonists have been
shown to increase ethanol consumption. Wild and Reid (1990) demonstrated that SpragueDawley rats given intracerebroventricular doses of morphine consumed more ethanol than their
vehicle counterparts during two bottle choice period following 22 hours of water deprivation,
and that this effect is due to central, rather than peripheral, mechanisms in the brain. This effect
is not confounded with other appetitive factors like sugar content; having been administered a
subcutaneous dose of morphine, Sprague-Dawley rats have been shown to have an increased
preference for a sweetened ethanol-sucrose solution over water during a two bottle choice period
following 18 hours of food and water deprivation, but not for the sucrose solution without
ethanol (Reid & Hunter, 1984).
Non-specific opioid receptor antagonists have been shown to decrease both ethanol
dependence and locomotor effects. In Swiss-Webster mice made physically dependent on
alcohol via ethanol vapor exposure, those mice that had been given naloxone exhibited
withdrawal behaviors 14 times less than those given a saline solution of equal volume, even
though both groups had equivalent concentrations of blood alcohol (Blum et al., 1977).
Moreover, mice (BALB/c, C57, or DBA/2) given a subcutaneous naltrexone (a non-specific
opioid receptor antagonist similar to naloxone; like naloxone it has preferential binding for MOP
and KOP, but has a higher affinity for DOP than naloxone (Nutt, 2014)) administration before
being injected intraperitoneally with ethanol did not exhibit ethanol hypnosis compared to
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experimental groups that received only saline injections and, with the exception of C57, did not
exhibit loss of righting reflex following ethanol exposure (Kiianmaa et al., 1983).
Non-specific opioid receptor antagonists alter ethanol preference. A 1mg/kg
administration of naloxone in Wistrar rats following the development of behavioral dependence
on ethanol acutely lowered ethanol consumption without affecting water consumption as part of
a two bottle choice, whereas behaviorally dependent rats given saline demonstrated no difference
in preference (Marfaing-Jallait et al., 1983). Likewise, subcutaneous naltrexone administration in
C57 mice following 2 weeks of ethanol exposure as part of a continuous two bottle choice
transiently reduced ethanol consumption and produced a long-lasting reduction in ethanol
preference (Middaugh & Bandy, 2000). Additionally, naloxone has been shown to decrease
motivation effects of alcohol. Rats implanted with lateral hypothalamic electrodes were
operantly trained to self-administer brain stimulation; following a pre-test control session, the
animals were then injected with saline or naloxone and then saline or ethanol and tested for 10
minutes .5, .2, 3.5, and 5 hours following injection (Lorens & Sainati, 1978). Those subjects that
received an ethanol and naloxone administration did not exhibit the increase in selfadministration present in those subjects that received an ethanol and saline administration.
Because naloxone was not shown to affect blood alcohol level, this indicates that naloxone
effectively blockaded the motivational effect of ethanol with regard to lateral hypothalamic selfstimulation.
2.1 Thesis Objectives
Endogenous opioids have been shown to play a significant role in motivation,
enforcement and addictive behaviors. Moreover, they have been found to interact with other
neurochemical systems in mediating alcohol behavioral and physiological effects. Opioid
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antagonists have been shown to effectively interrupt preferential and motivational effects of
alcohol consumption, and, by the same token, opioid agonists have been shown to effectively
raise preferential effects .In the research explored above, the blunting effect of opioid blockade
on the performance of extant addiction oriented behaviors has been demonstrated. What is of
interest, however, is if naloxone can block the consolidation of addiction reinforcement in the
first place, not only depressing preference or physical dependence with extant addiction, but
rather the learning about reward salience mediated by activation of the mesocortical dopamine
pathway during the first exposure to the drug of abuse.
2.2 Subjects
Subjects consisted of 25 C57 mice all of which had no prior ethanol exposure from
Taconic Laboratories (New York, NY, USA). Subjects were individually housed in ventilated
Plexiglas cages in a room maintained on a 12-12 reverse light dark cycle. The mean body weight
was 28.8 grams. This study was conducted in accordance with guidelines of the Guide to the
Care of the Use of Laboratory Animals, of the National Institutes of Mental Health. The animals
were maintained on ad libitum food (lab chow) and water except for the 24 h before exposure to
ethanol when food was withheld. Animals were returned to ad libitum conditions at other times.
Food deprivation was followed by two or three days of ad libitum food and water before each
deprivation period.
2.3 Procedure
Subjects were divided into four equal cohorts: two experimental cohorts, and two control
cohorts. Members of the first experimental cohort (n = 5) received a 5 mg/kg administration of
naloxone immediately after their first exposure to ethanol (2 cc of 3% ethanol), while members
of the second experimental cohort (n = 5) received a 5 mg/kg administration of saline (2 cc 0.9%
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NaC) vehicle immediately after their first exposure to ethanol (2 cc of 3% ethanol). The first of
the control cohort (n = 5) received a 5 kg/mg administration of naloxone following the fasting
period, but did not receive ethanol exposure. Likewise, the second control cohort (n = 5) received
a 5mg/kg administration of saline solution, but did not receive ethanol exposure. After three days
of exposure to ethanol under deprivation conditions accompanied by administrations of either
vehicle or naloxone, subjects then resumed a chow diet and were run on a two bottle choice
paradigm (Martinetti et al., 2000). One hour into the dark (active) cycle, each subject was
presented with a bottle of water and a bottle of 10% v/v ethanol solution. For one hour, each
subject was allowed to freely consume from either of the two bottles. The bottles, having been
pre-weighed, were then collected and re-weighed to determine the difference.
3.1 Statistical Analysis
Ethanol consumed
It was hypothesized that subjects which had been administered naloxone immediately
following ethanol exposure would consume less ethanol than subjects administered vehicle
immediately following ethanol exposure during a two bottle choice test. A one-way analysis of
variance (ANOVA) comparing the means of ethanol and water consumption supports this
hypothesis. While there is no significant between groups difference in the amount of water
consumed during the two-bottle choice test (F(3, 21) = 1.14, p = 0.36), there is a significant
between groups difference for the amount of ethanol consumed (F(3, 21) = 13.64, p < 0.05).
This difference is characterized by the outsized consumption of ethanol of the
naloxone-/ethanol+ group (M = 2.44, SE = 0.26). Compared to each other group –
naloxone+/ethanol+ (M = 1.00, SE = 0.07, p < 0.01), naloxone+/ethanol- (M = 1.34, SE = 0.18,
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p < 0.05), and naloxone-/ethanol- (M = 1.24, SE = 0.13, p < 0.05) – the naloxone-/ethanol+
group consumed a significantly larger amount of alcohol according to a Tukey’s range test.
The naloxone-/ethanol+ group is also the only cohort to exhibit a significant difference in
the amount of water and ethanol consumed within the group. An independent samples t-test
shows that whereas the naloxone+/ethanol+ (p = 0.36, t = 0.99), naloxone+/ethanol- (p = 0.93, t
= 0.09), and naloxone-/ethanol- (p = 0.13, t = 1.69) cohorts all had no statistically discrete
difference in the amount of water and ethanol consumed, the naloxone-/ethanol+ cohort (p <
0.01, t = 5.29) consumed significantly more ethanol than water. These data are summarized in
figure 1 below.

Figure 1: Figure 1 illustrates discrepancies in the amount of liquid consumed by each
group, measured in grams, during the two-bottle choice test.

Percent alcohol consumed
It was hypothesized that subjects which had been administered naloxone immediately
following ethanol exposure would not only consume less ethanol, but would consume less
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ethanol preferentially (i.e. ethanol would represent a smaller fraction of the total amount of liquid
consumed) than subjects which had been administered vehicle immediately following ethanol
exposure during a two bottle choice test. The percent alcohol consumed for each group was
calculated by taking the amount of ethanol consumed in grams and then dividing it by the total
amount of liquid consumed in grams.
A one-way ANOVA comparing percent alcohol consumed supports this hypothesis, but
not globally. A significant between groups difference was found (F(3, 21) = 3.78, p < 0.05), but
this held only for multiple comparisons between the naloxone-/ethanol+ cohort (M = 0.74, SE =
0.03) and the naloxone+/ethanol+ cohort (M = 0.48, SE = 0.09). There was no significant
difference in percent alcohol consumed between any of the other cohorts according to a Tukey’s
range test. These data are summarized in figure 2 below.

Figure 2: Figure 2 illustrates discrepancies in the percentage of alcohol consumed by
each group. Percent alcohol was determined by finding the ratio of alcohol consumed
over the total of all liquid consumed by each subject.
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3.2 General Discussion
These data clearly indicate that naloxone appears to have a blunting effect on the
consumption of alcohol, as seen in both less alcohol consumed and a greater proportion of water
consumed. The naloxone+/ethanol+ cohort behaved indistinguishably from those groups that had
never been exposed to alcohol in the first place. The key finding of these data, however, is that
naloxone can disrupt the acquisition of the reinforcing effects of alcohol addiction during the
initial exposure. Addiction is a process of the acquisition of new behaviors that are reinforced by
the effects of the drug. The increased striatal dopamine induced by exposure to a drug of abuse
creates an aberrantly powerful change in learning and memory compared to natural cues that
leads to sensitivity to environmental cues associated with consumption of drugs of abuse
(Torregrossa et al., 2011). Naloxone, as suggested by these data, interrupts that consolidation.
The pretreatment of the naloxone+/ethanol+ cohort led to a lower alcohol consumption in
comparison to animals that did not receive pretreatment: their relationship to alcohol during two
bottle choice exposure was no different than that of either of the control groups. The
naloxone+/ethanol+ cohort was in not particularly attentive to or motivated by the presence of
alcohol. On the other hand, the naloxone+/ethanol+ cohort seemed, also, to express a lower need
for alcohol consumption. This is reflected by the significant difference of ethanol consumption as
a fraction of total liquid consumption. To this end, the naloxone+/ethanol+ group was the only
cohort that differed in percent ethanol consumed from the naloxone-/ethanol+ cohort, and was
the only cohort to have consumed a significant difference of ethanol and water within the group.
In other words, members of the naloxone+/ethanol+ cohort had not only a lower preference for
alcohol consumption, but also a lower drive to consume ethanol than their naloxone-/ethanol+
cohort counterparts. Both the external (enhanced incentive) and internal (need) components of
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reinforcement were interrupted by the administration of naloxone and the attendant blockage of
opioid receptors.
This effect cannot be attributed to a difference in performance. Naloxone’s effect on
locomotor changes induced by ethanol has been explored above. Naloxone administered before
the exposure to ethanol could create changes in locomotor capacities that can be conflated with
changes in motivation. Since naloxone was administered after exposure to ethanol, its effect on
motivation cannot be confounded with locomotor changes.
An interesting observation is the increase, though non-significant, of water consumption
in the naloxone+/ethanol+ cohort. Across multiple animal models, naloxone has been found to
decrease food and water consumption following deprivation (Foster et al., 1981; Brown &
Holtzman, 1979). This appetitive decrease is tied to the primarily antidipsogenic action of
naloxone, which seems to have been counteracted in part by the exposure of alcohol. It could be
that the activation and dysregulation of appetitive systems that accompanies the development and
reinforcement of alcohol addiction could be responsible for this increase in water consumption,
but further research specifically investigating non-regulatory consumption of water is called for.
These data suggest questions for future research endeavors. For example, is naloxone’s
interruption of ethanol’s reinforcing effect dose dependent? A graded dose administration could
better define the extent of this effect. Additionally, what is the timing of this effect - could
naloxone blunt the reinforcing effect of ethanol after only one exposure? Is naloxone the best
tool for this effect? Naltrexone has a longer tail in its effect window, and has different nanomolar
affinities – would its administration produce the same outcome? Finally, there are observable
differences in striatal DA between men and women (Perry et al., 2016) - is there a discrepancy in
the extent of this effect between sexes?
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Future clinical research could also emphasize the use of naloxone as a potential
therapeutic tool for decreasing incentive mechanisms and drive components of alcohol and other
drugs of abuse as well as the treatment of obesity. Naloxone has been used in interventions
reversing the effects of alcoholic coma (Lyon & Anthony, 1982), so clinical applications have
already been explored. Naloxone could very well be folded into clinical rehabilitation protocols
in order to create extinction of incentive value during detoxification, for example, and aid in the
cessation of addictive behaviors.
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